Lucretia Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-01-2025
- Paid Up Capital ₹ 1.00 M
as on 04-01-2025
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Lucretia Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Lucretia Pharma Private Limited India is Dilipkumar Patel as CEO. Meeta Prajapati, Dilipkumar Patel, Bharatkumar Parmar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304GJ2016PTC092649
- Company No.
092649
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Sabarkantha, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Lucretia Pharma Private Limited offer?
Lucretia Pharma Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Vitamin Powder API.
Who are the key members and board of directors at Lucretia Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meeta Prajapati  | Managing Director | 24-Jun-2016 | Current |
| Dilipkumar Patel | CEO | 24-Jun-2016 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dilipkumar Patel | Director and Ceo | 24-Jun-2016 | Current |
| Bharatkumar Parmar | Director | 24-Jun-2016 | Current |
| Khilan Patel | Director | 27-Aug-2016 | Current |
| Kalkit Patel | Director | 22-Aug-2017 | Current |
Financial Performance of Lucretia Pharma.
Lucretia Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lucretia Pharma?
Unlock access to Lucretia Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lucretia Pharma?
Unlock and access historical data on people associated with Lucretia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lucretia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucretia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
